TGFB1 and neoplasm: It has been reported that NK cell functionality is inhibited by immunosuppressive cytokines found in the tumor milieu, such as ADO, which inhibits NK cell lytic activity [23], or TGF-β, which inhibits the differentiation of functional CD16+ NK cells from its CD16− counterparts [56].